Health Care

AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines
Analysts Say Medline Has The Secret Sauce For Sustained Growth
Analysts Say Medline Has The Secret Sauce For Sustained Growth
Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale
Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale
Analysts Say Medline Has The Secret Sauce For Sustained Growth
Analysts Say Medline Has The Secret Sauce For Sustained Growth
Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale
Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale
Johnson & Johnson Therapy Delivers Strong Results In Colorectal Cancer Trial
Johnson & Johnson Therapy Delivers Strong Results In Colorectal Cancer Trial
Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial
Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial

Health Care Recent News

Teva Taps Royalty Pharma For $500M To Advance Skin Disease Drug
Teva Taps Royalty Pharma For $500M To Advance Skin Disease Drug
Teva and Royalty Pharma have signed a deal worth up to $500 million to advance TEV-408, a drug being tested for vitiligo and celiac disease, with new trial results expected in 2026.
Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve
Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve
A U.S. court blocked Edwards Lifesciences' planned JenaValve acquisition after an FTC challenge. The company disagrees with the ruling.
Bill Gates Says Trump Aid Cuts Reversed Decades Of Global Health Progress As Child Deaths Rise
Bill Gates Says Trump Aid Cuts Reversed Decades Of Global Health Progress As Child Deaths Rise
Bill Gates said foreign aid cuts under the Trump administration reversed decades of global health progress, contributing to a rise in child deaths for the first time this century, while warning millions more could die without restored funding despite optimism around AI-driven innovation.
Bad News For Competitor Turns Into Big Win For ARS Pharma Stock
Bad News For Competitor Turns Into Big Win For ARS Pharma Stock
ARS Pharmaceuticals Inc. stock rose Friday as FDA identified deficiencies in rival Aquestive's application, delaying potential competition.
Beta Bionics Key KPI Miss Targets, Analyst Flags Valuation Risks
Beta Bionics Key KPI Miss Targets, Analyst Flags Valuation Risks
Beta Bionics reported Q4 2025 sales growth, but analysts raised concerns about valuation and slower patient starts.
Aquestive Stock Slides After FDA Flags Issues With Allergy Drug Application
Aquestive Stock Slides After FDA Flags Issues With Allergy Drug Application
Aquestive Therapeutics shares fall after the FDA flags deficiencies in its Anaphylm allergy drug application, raising approval delay concerns despite the review remaining active.
KalVista Details Early Sales, Prescriber Uptake For Newly Approved Rare Swelling Drug
KalVista Details Early Sales, Prescriber Uptake For Newly Approved Rare Swelling Drug
KalVista reports early EKTERLY sales momentum, rising prescriber adoption and global regulatory approvals following the drug's 2025 launch.
Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight
Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight
Eli Lilly said combining Taltz and Zepbound improved arthritis symptoms and drove meaningful weight loss, outperforming Taltz alone in a late-stage trial.
Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition
Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition
Haemonetics (HAE) to acquire Vivasure Medical Limited for 100 million euros upfront plus potential milestone payments.
Johnson & Johnson Secures Tariff Exemption Deal In Exchange For Drug Price Cuts
Johnson & Johnson Secures Tariff Exemption Deal In Exchange For Drug Price Cuts
Johnson & Johnson struck a deal with the Trump administration to lower drug prices for U.S. consumers in exchange for exemptions from tariffs.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved